Smith, Moore & Co’s Invesco Bloomberg Analyst Rating Improvers ETF UPGD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-2,895
Closed -$203K 530
2025
Q1
$203K Sell
2,895
-300
-9% -$21.3K 0.02% 463
2024
Q4
$221K Buy
3,195
+400
+14% +$28.9K 0.02% 440
2024
Q3
$201K Sell
2,795
-300
-10% -$20.5K 0.02% 450
2024
Q2
$203K Hold
3,095
0.02% 427
2024
Q1
$205K Buy
+3,095
New +$195K 0.02% 413
2022
Q1
Sell
-3,295
Closed -$207K 437
2021
Q4
$207K Buy
+3,295
New +$207K 0.03% 382

Other funds holding UPGD

Smith, Moore & Co's UPGD Position: Q2 2025 in Review

Smith, Moore & Co sold out of Invesco Bloomberg Analyst Rating Improvers ETF (UPGD) in Q2 2025, closing a stake of 2,895 shares — an estimated $203K sold.

Smith, Moore & Co first reported a position in UPGD in Q4 2021 and held it in 6 quarters. The position peaked at $221K in Q4 2024. 35 funds tracked by Wall St. Rank hold UPGD as of Q2 2025.

  • Smith, Moore & Co reported no remaining Invesco Bloomberg Analyst Rating Improvers ETF position as of Q2 2025 after selling out during the quarter.
  • Smith, Moore & Co sold 2,895 Invesco Bloomberg Analyst Rating Improvers ETF shares in Q2 2025, an estimated $203K.
  • Smith, Moore & Co first reported a position in Invesco Bloomberg Analyst Rating Improvers ETF in Q4 2021 and held it in 6 quarters.
  • Smith, Moore & Co's Invesco Bloomberg Analyst Rating Improvers ETF position peaked at $221K in Q4 2024.
  • 35 funds tracked by Wall St. Rank held Invesco Bloomberg Analyst Rating Improvers ETF as of Q2 2025.

Based on Smith, Moore & Co's 13F filing for Q2 2025, filed 13 Aug 2025.